Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
George C. Ebers(John Radcliffe Hospital)
Cited by 2,062
Related Papers
PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS
|DIAL (Catholic University of Leuven)|2001|472